• 

  Lynn Casteel Harper: Suffering No More—Reimagining Dementia for a Post-COVID World
• 

  A Virtual Microscope for Alzheimer’s Earns FDA ‘Breakthrough’ Designation
• 

  The Questions Doctors Are Getting About Aduhelm Right Now—And Their Answers
• 

  Neuroscientist Lisa Genova: How to Spot — and Prevent — Memory Loss
• 

  Will Insurance Companies and Medicare Cover Aduhelm’s High Price Tag?
• 

  A Retired Neurologist’s on His Own Alzheimer’s Journey
• 

  A Retired Neurologist On His Experience With Aduhelm’s Side Effects
• 

  Trial and Lots of Error: Experts Say Alzheimer’s Clinical Trials Need a Rethink
• 

  Olympic Gold Medalist Imran Sherwani Reveals Early-Onset Alzheimer’s Diagnosis
• 

  Amyloid Hypothesis in the Hot Seat After Aduhelm Approved for Alzheimer’s
• 

  What is an Aduhelm Infusion, and Why Was Its Approval So Controversial?
• 

  What Is Aduhelm and How Does It Fight Alzheimer’s?
• 

  Experts Respond to Aduhelm Approval
• 

  Our Experience With Aduhelm: Inside the Clinical Trial
• 

  Phil’s Journal: What’s Next for the Aducanumab Clinical Trial Rollercoaster?

Previous212223Next